| Example | STUDYID | DOMAIN | USUBJID | EXSEQ | EXTRT | EXDOSE | EXDOSU | EXDOSFRM | EXDOSFRQ | EXROUTE | EXADJ | EPOCH | EXSTDTC | EXENDTC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IG33_EX_EX_001 | 37841 | EX | 37841001 | 1 | DRUG A | 20 | mg | TABLET | QD | ORAL | TREATMENT | 2002-07-01 | 2002-10-01 | |
| IG33_EX_EX_001 | 37841 | EX | 37841002 | 1 | DRUG A | 20 | mg | TABLET | QD | ORAL | TREATMENT | 2002-04-02 | 2002-04-21 | |
| IG33_EX_EX_001 | 37841 | EX | 37841002 | 2 | DRUG A | 15 | mg | TABLET | QD | ORAL | Reduced due to toxicity | TREATMENT | 2002-04-22 | 2002-07-01 |
| IG33_EX_EX_001 | 37841 | EX | 37841003 | 1 | DRUG A | 20 | mg | TABLET | QD | ORAL | TREATMENT | 2002-05-09 | 2002-06-01 | |
| IG33_EX_EX_001 | 37841 | EX | 37841003 | 2 | DRUG A | 25 | mg | TABLET | QD | ORAL | Increased due to suboptimal efficacy | TREATMENT | 2002-06-02 | 2002-07-01 |
| IG33_EX_EX_001 | 37841 | EX | 37841003 | 3 | DRUG A | 30 | mg | TABLET | QD | ORAL | Increased due to suboptimal efficacy | TREATMENT | 2002-07-02 | 2002-08-01 |